New Alzheimer's Drug Slows Disease in Early Stages

Families facing early Alzheimer's just got something they haven't had before: the chance to slow the disease down and keep their loved ones independent longer.

UToledo Health is now offering Kisunla, an FDA-approved infusion therapy that targets the root cause of Alzheimer's by attacking amyloid plaques in the brain. These sticky protein clumps are linked to the memory loss and cognitive decline that steals people's independence.

The treatment represents a fundamental change in how doctors fight Alzheimer's. Dr. Alina Rais, a psychiatrist at UToledo Health, explains that medical teams used to focus only on temporarily improving symptoms. Now they can actually slow down how fast the disease progresses, especially when they catch it early.

Kisunla works through a 30-minute IV infusion once every four weeks. Patients need brain imaging before starting to make sure they're eligible and to monitor safety throughout treatment. The care team customizes how many infusions each person receives based on their individual needs.

The therapy is available for anyone with a confirmed diagnosis of early symptomatic Alzheimer's. No referral is needed, but patients must schedule an evaluation to determine if the treatment is right for them. The medical team reviews potential risks and side effects with each patient before starting.

The Ripple Effect

This advancement means more than just medical progress. It gives families precious additional time together while their loved one can still recognize faces, share stories, and participate in daily life. Every month of maintained independence matters deeply to someone watching a parent or spouse slowly disappear.

Insurance covers the infusion therapy, though prior authorization is required. UToledo Health staff helps patients navigate the approval process and verify their benefits, removing barriers that might prevent people from accessing this breakthrough treatment.

Patients can schedule an evaluation by calling UToledo Health at 419.383.5695 option 2 or emailing psychinfusion@utoledo.edu.

For millions of families who've felt helpless watching Alzheimer's take their loved ones piece by piece, this therapy offers something powerful: hope backed by science.